JPS5661314A - Preventive against side-effect for dialytic patient - Google Patents
Preventive against side-effect for dialytic patientInfo
- Publication number
- JPS5661314A JPS5661314A JP13803079A JP13803079A JPS5661314A JP S5661314 A JPS5661314 A JP S5661314A JP 13803079 A JP13803079 A JP 13803079A JP 13803079 A JP13803079 A JP 13803079A JP S5661314 A JPS5661314 A JP S5661314A
- Authority
- JP
- Japan
- Prior art keywords
- preventive
- carnitine
- patient
- dialytic
- actions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PURPOSE: A preventive for a dialytic patient against side effects, e.g., disorder of blood vessel of heart, weaking of the whole body, etc., comprising carnitine or its salt.
CONSTITUTION: A preventive comprising a dl-, d-, or l-derivative of carnitine shown by the formula or their pharmaceutically acceptable salts as an active ingredient. When a patient of renopathy, etc. is subjected to dialysis continuously, harmful actions such as disorder of blood vessel of heart, e.g, arrhythmia, myocardial infraction, etc., weakening of the whole body, giddiness, headache, etc. occur. But the administration of carmitine is capable of preventing and remedying these harmful actions. The preventive is prescribed orally or parenterally. The reason is uncertain, but the fact that carnitine or its salt reduces a concentration of fatty acid in the blood and has actions to promote the absorption of long-chain Acyl- CoA to mitochondria membtane and to improve the energy metabolism of cardiac muscle is considered to be related to the reason.
COPYRIGHT: (C)1981,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13803079A JPS5661314A (en) | 1979-10-24 | 1979-10-24 | Preventive against side-effect for dialytic patient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13803079A JPS5661314A (en) | 1979-10-24 | 1979-10-24 | Preventive against side-effect for dialytic patient |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2212937A Division JPH06102624B2 (en) | 1990-08-10 | 1990-08-10 | Anti-arrhythmic drugs of non-heart origin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5661314A true JPS5661314A (en) | 1981-05-26 |
JPH0440328B2 JPH0440328B2 (en) | 1992-07-02 |
Family
ID=15212397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13803079A Granted JPS5661314A (en) | 1979-10-24 | 1979-10-24 | Preventive against side-effect for dialytic patient |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5661314A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60156613A (en) * | 1984-01-24 | 1985-08-16 | Japan Hosupitaru Supply:Kk | Preventive agent for dialysis shock |
GB2230953A (en) * | 1989-05-05 | 1990-11-07 | Sigma Tau Ind Farmaceuti | Compositions containing D-carnitine or an acyl derivative for the treatment of protozoal disease |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54151130A (en) * | 1978-05-15 | 1979-11-28 | Cavazza Claudio | Treating agent for kidney disease |
-
1979
- 1979-10-24 JP JP13803079A patent/JPS5661314A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54151130A (en) * | 1978-05-15 | 1979-11-28 | Cavazza Claudio | Treating agent for kidney disease |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60156613A (en) * | 1984-01-24 | 1985-08-16 | Japan Hosupitaru Supply:Kk | Preventive agent for dialysis shock |
GB2230953A (en) * | 1989-05-05 | 1990-11-07 | Sigma Tau Ind Farmaceuti | Compositions containing D-carnitine or an acyl derivative for the treatment of protozoal disease |
GB2230953B (en) * | 1989-05-05 | 1993-03-24 | Sigma Tau Ind Farmaceuti | Compositions containing d-carnitine or an acyl derivative for the treatment of protozoal disease |
Also Published As
Publication number | Publication date |
---|---|
JPH0440328B2 (en) | 1992-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Grob et al. | Effects in man of the anticholinesterase compound sarin (isopropyl methyl phosphonofluoridate) | |
EP0588379B1 (en) | Treatment of wrinkling | |
Brass et al. | Relationship between acid-soluble carnitine and coenzyme A pools in vivo | |
KR840003414A (en) | Pharmaceutical compositions containing 3-hydroxybutanoic acid or salts derived from these acids, and compounds derived from 3-hydroxybutanoic acid that can be used as pharmaceuticals | |
KR920000324A (en) | Essential Fatty Acid Treatment | |
EP0234733A1 (en) | Pharmaceutical compositions | |
FR2439187A1 (en) | SUBSTITUTED 1-PIPERAZINE-CARBOXAMIDES AND -CARBOTHIOAMIDES DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
JPS5735512A (en) | Preventive and remedy for thrombosis | |
Campion et al. | Rhabdomyolysis and myoglobinuria: association with hypokalemia of renal tubular acidosis | |
Gray et al. | An L-arginine-derived factor mediates endotoxin-induced vascular hyposensitivity to calcium | |
JPS5661314A (en) | Preventive against side-effect for dialytic patient | |
Tellioglu et al. | The effect of carnitine on random-pattern flap survival in rats | |
KR940006576A (en) | Use of L-carnitine and acyl L-carnitine for the treatment of AIDS and AIDS-related syndrome patients and asymptomatic HIV seropositive patients | |
Dubowitz et al. | Acute dermatomyositis presenting with pulmonary manifestations | |
Dupler | Ventricular arrhythmia and Stokes-Adams syndrome: report of a case | |
IE790157L (en) | Therapeutic agents | |
Barnes et al. | Hypokalaemic myopathy and myoglobinuria due to carbenoxolone sodium. | |
Sundaram et al. | Total body potassium depletion and severe myopathy due to chronic liquorice ingestion | |
Miller et al. | Prolonged use of massive doses of urea in cardiac dropsy | |
GORDON | Treatment of ichthyosis | |
GB1517139A (en) | Composition active with respect to erythema solare | |
Bine | The treatment of heart failure and the use of digitalis in myocardial infarction | |
Lawanlakkana et al. | Comparing the effect between oral and injection form of carnitine on skin flap survival in rats | |
Rangaswami | Difficulties in arousing and increasing heterosexual responsiveness in a homosexual: A case report. | |
Viru et al. | Effect of creatine intake on the performance capacity in middle distance runners |